Could a simple drink replace feeding tubes for head and neck cancer patients?
NCT ID NCT07242365
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tests whether Soylent, a liquid meal replacement, can help head and neck cancer patients avoid needing a feeding tube during chemoradiotherapy. About 60 patients with locally advanced cancer will drink Soylent alongside their treatment. The goal is to see if this reduces malnutrition and the need for gastrostomy tube placement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Soylent liquid meal replacement
What this could lead to
If it works, this could offer a simple nutritional drink to help patients avoid feeding tubes during cancer treatment.
What could go wrong
This is a small, early-phase study with only 60 participants, so results may not apply to everyone. The drink may not be enough to prevent malnutrition or tube placement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States